- Home
- ICFI vs OCUL Comparison
ICFI vs OCUL Comparison
Compare ICFI & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICFI | OCUL |
|---|---|---|
| Founded | 1969 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ICFI | OCUL |
|---|---|---|
| Price | $66.69 | $8.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $99.25 | $22.90 |
| AVG Volume (30 Days) | 217.1K | ★ 6.0M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.95 | N/A |
| Revenue | ★ $1,229,162,000.00 | $1,990,000.00 |
| Revenue This Year | $4.60 | $9.35 |
| Revenue Next Year | $4.75 | $92.88 |
| P/E Ratio | $13.41 | ★ N/A |
| Revenue Growth | ★ 3.72 | 3.48 |
| 52 Week Low | $65.82 | $6.23 |
| 52 Week High | $101.71 | $16.44 |
Technical Indicators
Market Signals| Indicator | ICFI | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 27.45 | 39.37 |
| Support Level | N/A | $6.23 |
| Resistance Level | $89.69 | $12.20 |
| Average True Range (ATR) | 2.82 | 0.62 |
| MACD | -0.53 | -0.13 |
| Stochastic Oscillator | 3.68 | 0.62 |
Price Performance
Historical ComparisonAbout ICFI ICF International Inc.
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.